The impact of cannabis use on cognitive functioning in patients with schizophrenia: A meta-analysis of existing findings and new data in a first-episode sample

235Citations
Citations of this article
369Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cannabis use is highly prevalent among people with schizophrenia, and coupled with impaired cognition, is thought to heighten the risk of illness onset. However, while heavy cannabis use has been associated with cognitive deficits in long-term users, studies among patients with schizophrenia have been contradictory. This article consists of 2 studies. In Study I, a meta-analysis of 10 studies comprising 572 patients with established schizophrenia (with and without comorbid cannabis use) was conducted. Patients with a history of cannabis use were found to have superior neuropsychological functioning. This finding was largely driven by studies that included patients with a lifetime history of cannabis use rather than current or recent use. In Study II, we examined the neuropsychological performance of 85 patients with first-episode psychosis (FEP) and 43 healthy nonusing controls. Relative to controls, FEP patients with a history of cannabis use (FEP + CANN; n = 59) displayed only selective neuropsychological impairments while those without a history (FEP - CANN; n = 26) displayed generalized deficits. When directly compared, FEP + CANN patients performed better on tests of visual memory, working memory, and executive functioning. Patients with early onset cannabis use had less neuropsychological impairment than patients with later onset use. Together, these findings suggest that patients with schizophrenia or FEP with a history of cannabis use have superior neuropsychological functioning compared with nonusing patients. This association between better cognitive performance and cannabis use in schizophrenia may be driven by a subgroup of "neurocognitively less impaired" patients, who only developed psychosis after a relatively early initiation into cannabis use. © The Author 2010. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved.

References Powered by Scopus

The positive and negative syndrome scale (PANSS) for schizophrenia

18355Citations
N/AReaders
Get full text

Specific impairments of planning.

3094Citations
N/AReaders
Get full text

The MATRICS consensus cognitive battery, part 1: Test selection, reliability, and validity

1905Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder

300Citations
N/AReaders
Get full text

Keep off the grass? Cannabis, cognition and addiction

296Citations
N/AReaders
Get full text

Cannabis and adolescent brain development

256Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yücel, M., Bora, E., Lubman, D. I., Solowij, N., Brewer, W. J., Cotton, S. M., … Pantelis, C. (2012). The impact of cannabis use on cognitive functioning in patients with schizophrenia: A meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin, 38(2), 316–330. https://doi.org/10.1093/schbul/sbq079

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 127

59%

Researcher 49

23%

Professor / Associate Prof. 28

13%

Lecturer / Post doc 10

5%

Readers' Discipline

Tooltip

Psychology 102

44%

Medicine and Dentistry 80

34%

Neuroscience 31

13%

Agricultural and Biological Sciences 21

9%

Article Metrics

Tooltip
Mentions
Blog Mentions: 2
News Mentions: 2
Social Media
Shares, Likes & Comments: 14

Save time finding and organizing research with Mendeley

Sign up for free